Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

Deuruxolitinib effectively promotes hair regrowth in alopecia areata.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Leukemia can sometimes appear as unusual skin issues in children.

ADMSC-derived exosomes may effectively treat steroid-resistant alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Ruxolitinib cream may help treat severe hair loss in children.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Upadacitinib effectively treats severe alopecia areata and is safe.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

CS12192 effectively treats alopecia areata with better safety than current options.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

The treatment was not recommended due to limited effectiveness and significant side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Ritlecitinib can help about 14,000 people with severe hair loss.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Interleukin-15 can help hair growth and protect hair follicles.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.